跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIEKA CAPSULE 75MG - HSA Drug Approval Details
Approvals
/
HSA
/
BRIEKA CAPSULE 75MG
Approved
THERAPEUTIC
BRIEKA CAPSULE 75MG
BALKANPHARMA-DUPNITSA AD (BULGARIA)
🇸🇬 Health Sciences Authority
Approval Date
Jan 23, 2018
Approval ID
ab4666dbefd7e300
Company
BALKANPHARMA-DUPNITSA AD (BULGARIA)
Type
Therapeutic
Approval Details
Approval Id
ab4666dbefd7e300
Drug Name
BRIEKA CAPSULE 75MG
Product Name
BRIEKA CAPSULE 75MG
Approval Number
SIN15409P
Approval Date
2018-01-23
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
N03AX16
Atc Item Name
xn 03 ax 16
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
Pregabalin
75.00 mg
PREGABALIN
75 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 23, 2018
Approval ID
ab4666dbefd7e300
Type
Therapeutic
Back to HSA Approvals